Cargando…
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbations are heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic acid (LPA) has been implicated in airway inflammation but the significance of LPA in COPD exacerbation is not known. The aim of the s...
Autores principales: | Li, Qingling, Wong, Weng, Birnberg, Andrew, Chakrabarti, Arindam, Yang, Xiaoying, Choy, David F., Olsson, Julie, Verschueren, Erik, Neighbors, Margaret, Sandoval, Wendy, Rosenberger, Carrie M., Grimbaldeston, Michele A., Tew, Gaik W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461999/ https://www.ncbi.nlm.nih.gov/pubmed/34556083 http://dx.doi.org/10.1186/s12890-021-01670-9 |
Ejemplares similares
-
Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis
por: Neighbors, Margaret, et al.
Publicado: (2023) -
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
por: Chakrabarti, Arindam, et al.
Publicado: (2021) -
Comparison of genome-wide gene expression profiling by RNA Sequencing versus microarray in bronchial biopsies of COPD patients before and after inhaled corticosteroid treatment: does it provide new insights?
por: Ditz, Benedikt, et al.
Publicado: (2021) -
Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015) -
A bronchial gene signature specific for severe COPD that is retained in the nose
por: van Nijnatten, Jos, et al.
Publicado: (2023)